Related Experiment Video
Updated: Jun 13, 2026

Field Identification of Matricaria chamomilla using a Portable qPCR System
Published on: October 10, 2020
Lessons learned from herbal medicinal products: the example of St. John's Wort (perpendicular)
Adolf Nahrstedt1, Veronika Butterweck
1Institute of Pharmaceutical Biology and Phytochemistry, Westfalische Wilhelms-Universitat, D-48149 Munster, Germany. anahrstedt@uni-muenster.de
Abstract:
The example of St. John's wort offers convincing evidence for the concept that modern methods of pharmacological and phytochemical research are effective in advancing the development of traditional herbal remedies. As a consequence of these efforts, it is known today that several compounds from different structural groups and with different mechanisms of action seem to be responsible for the observed antidepressant efficacy of St. John's Wort. Co-effectors in the extract improve the bioavailability of active constituents such as hypericin (1) (pharmacokinetic synergy). Unwanted side effects are preventable without remarkable loss of activity when the responsible constituent(s) are carefully removed during the extraction process, as demonstrated for hyperforin (3), which is responsible for the induction of cytochrome P450 (CYP)-metabolizing enzymes (CYP3A4, in particular). On the basis of our findings, it is likely that positive interactions between single compounds occur more frequently in traditionally used herbal preparations than is known presently.
Related Concept Videos
Drug Administration and Therapy Phases: Overview
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
